Androgen and Androgen Receptor in Kidney Cancer
Journal Title: Nephrology – Open Journal - Year 2015, Vol 1, Issue 2
Abstract
Kidney cancer is one of the top ten most common cancers in men and women. There are four types of kidney cancer, including Renal Cell Carcinoma (RCC), Transitional cell carcinoma, renal sarcoma, and Wilm’s tumor. The most common type of kidney cancers is renal cell carcinoma (RCC), with around nine out of ten kidney cancers being RCC (American Cancer Associate). Epidemiology studies have identified several risk factors associated with kidney cancer.1 Among them, male gender is associated with twice incidence rate of RCC as female.2 Androgen and Androgen Receptor (AR) are major factors contributing to malegender-associated-diseases, such as prostate cancer,3 suggesting that androgen and AR might be involved in RCC development and progression.
Authors and Affiliations
Chiung-Kuei Huang
Keywords
Related Articles
- EP ID EP558148
- DOI 10.17140/NPOJ-1-e003
- Views 198
- Downloads 0
Extensive Search for Dry Weight: Should We Change the Strategy?
Introduction: A wrong estimate of the dry weight in hemodialysis patients increases their morbidity and mortality. The aim of our study was to compare the results of the estimated dry weight using the clinical examinatio...
The Unfolded Protein Response: A Novel Insight into Chronic Kidney Disease (CKD)
Chronic kidney disease (CKD) is a clinical syndrome, characterized by a progressive decline of renal function. CKD is associated with a wide range of metabolic abnormalities including hypertension, anemia, acidosis, and...
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
Obesity has become a worldwide epidemic, and its prevalence has been projected to grow by 40% in the next decade. This increasing prevalence has implications for the risk of diabetes, cardiovascular disease and also for...
Involvement of NF-κB Signaling Pathway in the Pathogenesis of Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by accumulation of anti-nuclear autoantibodies, hyperactivation. It can affect any organ, including brain, skin, joint, and kidney. The nu...
Review of the REPRISE Trial: Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
In the past, Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) and its Outcomes (TEMPO) trial showed Tolvaptan, a vasopressin V2-receptor antagonist, slowed the decline i...